行情

ARMP

ARMP

Armata医药
AMEX
2.010
-0.090
-4.29%
已收盘, 16:00 11/29 EST
开盘
2.111
昨收
2.100
最高
2.260
最低
2.010
成交量
1.75万
成交额
3.45万
52周最高
6.46
52周最低
1.850
市值
7,265.09万
市盈率(TTM)
-1.9566
分时
5日
1月
3月
1年
5年
暂无数据
ARMP 简况
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using bacteriophage-based technology. It has developed care therapies, including the multidrug-resistant or superbug strains of bacteria. The Company is a developer of phage therapeutics, which are positioned to address the growing worldwide threat of antibiotic-resistant bacterial infections. It is developing and advancing its lead clinical phage candidate for Pseudomonas aeruginosa. The Company is also developing a phage product candidate for Staphylococcus aureus for the treatment of staphylococcus aureus bacteremia. It has phage development to target other indications, including non-cystic fibrosis bronchiectasis (NCFB), prosthetic joint infections (PJI) and hospitalized pneumonia. Its product candidates are AP-PA02, AP-PA03 and AP-SA02.

微牛提供Armata Pharmaceuticals Inc(AMEX-ARMP)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的ARMP股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ARMP股票基本功能。